GGrantIndex
← Leaderboards

Gordana Vunjak-Novakovic

Tufts University Medford

$50,226,975
Attributed
$60,563,083
Total exposure
28
Grants
25
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.4M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$70,473,941 · 29

By mechanism

R01$25,947,017 · 5
P41$17,700,239 · 13
UH3$11,091,207 · 2
U01$8,498,041 · 1
UG3$2,778,517 · 1
R21$1,869,129 · 5

Top collaborators

Most similar at Tufts University Medford

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignCellsTissuesEngineeringTissue EngineeringResponseModalityIn VitroTechnologyInsightInnovationNatural RegenerationBioreactorsBlood VesselsImagePerfusionIn VivoBiomedical EngineeringInduced Pluripotent Stem CellCardiacBaseScaffoldHeartBiological

Grant awards (126)

Tissue Engineering Resource Center$1,349,983
P41 · FY2025 · EB · contact PI
Engineering Vascularized Cardiac Muscle$625,367
R01 · FY2025 · HL · contact PI
Tissue Engineering Resource Center: Admin-Core$269,997
P41 · FY2025 · EB · contact PI
Tissue Engineering Resource Center: TTD$269,996
P41 · FY2025 · EB · contact PI
Tissue Engineering Resource Center: TR&D3$269,996
P41 · FY2025 · EB · contact PI
Tissue Engineering Resource Center$1,255,354
P41 · FY2024 · EB · contact PI
Engineering Vascularized Cardiac Muscle$612,859
R01 · FY2024 · HL · contact PI
Cancer patient on a chip$495,953
R01 · FY2024 · CA · contact PI
Tissue Engineering Resource Center: TR&D3$445,884
P41 · FY2024 · EB · contact PI
Tissue Engineering Resource Center: Admin-Core$96,810
P41 · FY2024 · EB · contact PI
Tissue Engineering Resource Center: TTD$55,247
P41 · FY2024 · EB · contact PI
Tissue Engineering Resource Center$1,315,637
P41 · FY2023 · EB · contact PI
Engineering Vascularized Cardiac Muscle$641,492
R01 · FY2023 · HL · contact PI
Cancer patient on a chip$511,615
R01 · FY2023 · CA · contact PI
Tissue Engineering Resource Center$410,448
P41 · FY2023 · EB · contact PI
Tissue Engineering Resource Center$128,172
P41 · FY2023 · EB · contact PI
Tissue Engineering Resource Center$90,651
P41 · FY2023 · EB · contact PI
Tissue Engineering Resource Center$67,728
P41 · FY2023 · EB · contact PI
Tissue Engineering Resource Center$1,334,514
P41 · FY2022 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$1,262,972
U01 · FY2022 · HL
Bioengineering a chimeric human lung$842,444
R01 · FY2022 · HL · contact PI
Engineering Vascularized Cardiac Muscle$634,867
R01 · FY2022 · HL · contact PI
Cancer patient on a chip$511,615
R01 · FY2022 · CA · contact PI
Tissue Engineering Resource Center$409,945
P41 · FY2022 · EB · contact PI
Tissue Engineering Resource Center$128,015
P41 · FY2022 · EB · contact PI
Tissue Engineering Resource Center$67,644
P41 · FY2022 · EB · contact PI
Tissue Engineering Resource Center$60,435
P41 · FY2022 · EB · contact PI
Tissue Engineering Resource Center$1,315,331
P41 · FY2021 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$1,264,156
U01 · FY2021 · HL
Multi-tissue platform for modeling systemic pathologies$1,228,168
UH3 · FY2021 · EB · contact PI
Bioengineering a chimeric human lung$842,444
R01 · FY2021 · HL · contact PI
Engineering Vascularized Cardiac Muscle$634,867
R01 · FY2021 · HL · contact PI
Cancer patient on a chip$522,055
R01 · FY2021 · CA · contact PI
Tissue Engineering Resource Center$401,708
P41 · FY2021 · EB · contact PI
Tissue Engineering Resource Center$125,444
P41 · FY2021 · EB · contact PI
Tissue Engineering Resource Center$66,285
P41 · FY2021 · EB · contact PI
Tissue Engineering Resource Center$1,349,613
P41 · FY2020 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$1,265,305
U01 · FY2020 · HL
Multi-tissue platform for modeling systemic pathologies$1,228,168
UH3 · FY2020 · EB · contact PI
Bioengineering a chimeric human lung$842,444
R01 · FY2020 · HL · contact PI
Engineering Vascularized Cardiac Muscle$634,867
R01 · FY2020 · HL · contact PI
Cancer patient on a chip$522,055
R01 · FY2020 · CA · contact PI
Tissue Engineering Resource Center-Treatment of COVID-19 induced acute respiratory distress by inhalation of exosomes$467,004
P41 · FY2020 · EB · contact PI
Tissue Engineering Resource Center$467,004
P41 · FY2020 · EB · contact PI
Tissue Engineering Resource Center$409,871
P41 · FY2020 · EB · contact PI
Tissue Engineering Resource Center$127,991
P41 · FY2020 · EB · contact PI
Tissue Engineering Resource Center$67,632
P41 · FY2020 · EB · contact PI
Tissue Engineering Resource Center$1,372,336
P41 · FY2019 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$1,261,011
U01 · FY2019 · HL
Multi-tissue platform for modeling systemic pathologies$1,243,667
UH3 · FY2019 · EB · contact PI
Bioengineering a chimeric human lung$842,444
R01 · FY2019 · HL · contact PI
Engineering Vascularized Cardiac Muscle$650,367
R01 · FY2019 · HL · contact PI
Tissue Engineering Resource Center$414,648
P41 · FY2019 · EB · contact PI
Multi-tissue platform for modeling systemic pathologies$305,740
UH3 · FY2019 · EB · contact PI
Multi-tissue platform for modeling systemic pathologies$296,057
UG3 · FY2019 · EB · contact PI
Tissue Engineering Resource Center$129,484
P41 · FY2019 · EB · contact PI
Tissue Engineering Resource Center$68,421
P41 · FY2019 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$1,262,369
U01 · FY2018 · HL
Multi-tissue platform for modeling systemic pathologies$1,226,230
UG3 · FY2018 · EB · contact PI
Multi-tissue platform for modeling systemic pathologies$1,256,230
UG3 · FY2017 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$955,428
U01 · FY2017 · HL
Bioengineering a Chimeric Human Lung$546,783
R01 · FY2017 · HL · contact PI
Craniofacial Tissue Engineering$512,557
R01 · FY2017 · DE · contact PI
Engineering vascularized cardiac muscle.$451,899
R01 · FY2017 · HL · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$272,000
U01 · FY2017 · HL
Integrated heart-liver-vascular systems for drug testing in human health and dise$2,101,473
UH3 · FY2016 · EB · contact PI
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis$954,800
U01 · FY2016 · HL
Bioengineering a Chimeric Human Lung$545,960
R01 · FY2016 · HL · contact PI
Craniofacial Tissue Engineering$506,658
R01 · FY2016 · DE · contact PI
Engineering vascularized cardiac muscle.$451,899
R01 · FY2016 · HL · contact PI
Advanced Multiscale Bioreactors ^ from Basic Biology to Tissue Engineering$305,490
P41 · FY2016 · EB · contact PI
Translational Bioreactors - Engineering Complex Tissues$305,489
P41 · FY2016 · EB · contact PI
Tissue Chips for Rare Disease: Adding Timothy Syndrome to the HeLIVaSkCa platform$158,240
UH3 · FY2016 · EB · contact PI
Tissue chip for integrating testis as a missing organ$79,890
UH3 · FY2016 · EB · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$2,092,852
UH3 · FY2015 · EB · contact PI
Electrotherapeutic strategies for connective tissue repair$625,321
R01 · FY2015 · AR
Bioengineering a Chimeric Human Lung$538,439
R01 · FY2015 · HL · contact PI
Craniofacial Tissue Engineering$532,181
R01 · FY2015 · DE · contact PI
Engineering vascularized cardiac muscle.$445,121
R01 · FY2015 · HL · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$239,688
UH3 · FY2015 · EB · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$200,000
UH3 · FY2015 · EB · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$121,000
UH3 · FY2015 · EB · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$2,092,321
UH3 · FY2014 · EB · contact PI
Electrotherapeutic strategies for connective tissue repair$620,444
R01 · FY2014 · AR
Bioengineering a Chimeric Human Lung$536,360
R01 · FY2014 · HL · contact PI
Craniofacial Tissue Engineering$474,736
R01 · FY2014 · DE · contact PI
Engineering vascularized cardiac muscle.$437,229
R01 · FY2014 · HL · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$735,429
UH2 · FY2013 · EB · contact PI
Electrotherapeutic strategies for connective tissue repair$609,262
R01 · FY2013 · AR
Bioengineering a Chimeric Human Lung$522,255
R01 · FY2013 · HL · contact PI
Craniofacial Tissue Engineering$482,579
R01 · FY2013 · DE · contact PI
Engineering vascularized cardiac muscle.$439,735
R01 · FY2013 · HL · contact PI
Integrated heart-liver-vascular systems for drug testing in human health and dise$160,500
UH2 · FY2013 · EB · contact PI
Nanion Syncro Patch 96$913,875
S10 · FY2012 · OD
Integrated heart-liver-vascular systems for drug testing in human health and dise$779,987
UH2 · FY2012 · EB · contact PI
Electrotherapeutic strategies for connective tissue repair$645,728
R01 · FY2012 · AR
Enhancing survival and function of engineered cardiac tissue$202,329
R21 · FY2012 · HL · contact PI
Plug and Play Bioreactor$192,866
R21 · FY2012 · EB · contact PI
Electrotherapeutic strategies for connective tissue repair$659,141
R01 · FY2011 · AR
Enhancing survival and function of engineered cardiac tissue$258,554
R21 · FY2011 · HL · contact PI
Plug and Play Bioreactor$192,866
R21 · FY2011 · RR · contact PI
Silk hydrogel for functional cartilage tissue engineering$188,535
R21 · FY2011 · EB · contact PI
Silk hydrogel for functional cartilage tissue engineering$236,065
R21 · FY2010 · EB · contact PI
Plug and Play Bioreactor$194,814
R21 · FY2010 · RR · contact PI
Craniofacial Tissue Engineering$548,806
R01 · FY2009 · DE · contact PI
Engineering Vascularized Cardiac Muscle$378,543
R01 · FY2009 · HL · contact PI
Craniofacial Tissue Engineering$263,339
R01 · FY2009 · DE · contact PI
Controlled gene delivery for in vivo vascularization of an engineered cardiac pat$173,800
R21 · FY2009 · HL · contact PI
Engineering Vascularized Cardiac Muscle$9,297
R01 · FY2009 · HL · contact PI
Craniofacial Tissue Engineering$6,252
R01 · FY2009 · DE · contact PI
CORE -- TISSUE ENGINEERING BIOREACTOR$671,435
P41 · FY2008 · EB · contact PI
Craniofacial Tissue Engineering$541,124
R01 · FY2008 · DE · contact PI
Engineering Vascularized Cardiac Muscle$373,519
R01 · FY2008 · HL · contact PI
Controlled gene delivery for in vivo vascularization of an engineered cardiac pat$229,300
R21 · FY2008 · HL · contact PI
Engineering Vascularized Cardiac Muscle$119,744
R01 · FY2008 · HL · contact PI
CORE -- TISSUE ENGINEERING BIOREACTOR$720,533
P41 · FY2007 · EB · contact PI
Craniofacial Tissue Engineering$542,490
R01 · FY2007 · DE · contact PI
Engineering Vascularized Cardiac Muscle$337,800
R01 · FY2007 · HL · contact PI
Engineering Vascularized Cardiac Muscle$17,066
R01 · FY2007 · HL · contact PI
Craniofacial Tissue Engineering$546,012
R01 · FY2006 · DE · contact PI
Engineering Vascularized Cardiac Muscle$346,162
R01 · FY2006 · HL · contact PI
CORE -- TISSUE ENGINEERING BIOREACTOR$269,070
P41 · FY2006 · EB · contact PI
Craniofacial Tissue Engineering$589,990
R01 · FY2005 · DE
Engineering Vascularized Cardiac Muscle$374,831
R01 · FY2005 · HL
CORE -- TISSUE ENGINEERING BIOREACTOR$269,500
P41 · FY2005 · EB
CORE -- TISSUE ENGINEERING BIOREACTOR$349,494
P41 · FY2004 · EB